ARK Genomic Revolution UCITS ETF

—Index replication
AccumulatingDistribution policy
0.75 %TER
£81.66M Fund size
33Number of positions
-2.42 % TD
57.16 %Top 10 share
USDCurrency
6SRI

Current price

£5.97
19 Nov 2026
1D
1W
1M
3M
6M
1Y
3Y
Max

Description

The ARK Genomic Revolution UCITS ETF (the "Fund") is actively managed and invests primarily in global equity securities of companies involved in the genomic revolution. These are companies that are substantially focused on or benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments, improvements and advancements in genomics into their business, such as by offering new products or services that rely on genomic sequencing, analysis, synthesis or instrumentation. These companies may include ones across multiple sectors, such as healthcare, information technology, materials, energy and consumer discretionary. These companies may also develop, produce, manufacture or significantly rely on or enable bionic devices, bio-inspired computing, bioinformatics, molecular medicine and agricultural biotechnology. The investment manager uses both “top down” approaches (thematic research sizing the potential total available market for each technology, and identifying the prime leaders, enablers and beneficiaries of the innovation) and “bottom up” approaches (valuation, fundamentals and quantitative measures relating to individual companies) to select companies. The “top down” approach explicitly selects for technologies that the Investment Manager anticipates will make a meaningful contribution to at least two of the United Nations Sustainable Development Goals. The “bottom up” approach to company selection integrates ESG considerations such as business involvement, violations of international norms and standards and an assessment of controversies, environmental and social risks and governance. DIVIDEND POLICY. This Share Class does not intend to pay dividends. Any income which may result from the Fund’s investments will be re- invested into the Fund. DEALING. Shares in this Share Class (the “Shares”) are denominated in USD and can be bought and sold on stock exchanges by ordinary investors using an intermediary (e.g. a stockbroker). In normal circumstances, only Authorised Participants may buy and sell Shares directly with the ICAV. Authorised Participants may redeem their Shares on demand in accordance with the “Dealing Timetable” published on https://arkeurope.com/

Return

Here you can see the performance (incl. distributions) of the ARK Genomic Revolution UCITS ETF.

Period Perfor­mance
1 Week-9.82 %
1 Month-10.01 %
3 Months-1.30 %
6 Months+47.73 %
1 Year+54.33 %
3 Years—
5 Years—
10 Years—
Since inception +51.50 %(17.32 % p.a.)
Year Perfor­mance
YTD+45.60 %
2025+8.90 %
2024+4.76 %
2023—
2022—
2021—
As of: 18 Nov 2026. Performance displayed in GBP

Master data

Key master data for the ARK Genomic Revolution UCITS ETF

Total expense ratio (TER) 0.75 %
Index replication —
Replication method Other
Distribution policy Accumulating
Fund size £81.66M
Fund launch 12 Apr 2024
Fund currency USD
Currency hedging No 
Fund domicileIrland
Risk indicator (SRI)
6 · second-highest risk class

Risk metrics

Key risk and analysis metrics for the ARK Genomic Revolution UCITS ETF

Volatility
41.88 % 1 Year
— 3 Years
— 5 Years
max. Drawdown
-13.97 % 1 Year
— 3 Years
— 5 Years
Sharpe Ratio
1.34 1 Year
— 3 Years
— 5 Years
XLM
55.92

Information about the MSCI World NR USD Index

Index name MSCI World NR USD (1)
Included securities 33
Stock positions 33
Bond positions 0
Cash and other positions 0

More ETFs tracking the MSCI World NR USD Index

Here you can find alternative index funds for the MSCI World NR USD.

Fund nameWKNTER
No results

Frequently asked questions

Here you will find all answers to your questions about the ARK Genomic Revolution UCITS ETF

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.